NSEAnalysts/Institutional Investor Meet/Con. Call Updates13h ago · 31 Oct 2026, 03:39 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Supriya Lifescience Limited · SUPRIYA

✦ AI SummaryResults

Supriya Lifescience Limited has informed the Exchange about Schedule of meet for Earnings Call to discuss operational and financial performance for Q2 FY27 on November 06, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Supriya Lifescience Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

SUPRIYA_31102026153717_SEIntimationEarCall311026.pdf

pdf

Download →
View document text
October 31, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir/Madam, Subject: Intimation of Earnings Call for Unaudited Financial Results for quarter and half year ended September 30, 2026. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Friday, November 06, 2026, at 05.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2026. The invite giving requisite details including the pre-registration link and dial-in details are enclosed herewith. The investor presentation shall be shared with the Exchanges separately. Kindly take the information on record. Thanking you, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE Supriya Lifescience Ltd cordially invites you to their Earnings Call to discuss operational and financial performance for Q2 FY27 Friday, November 6, 2026 at 5:00 PM, IST Access Numbers Diamond Pass Registration Link +91 22 6280 1107 Primary Number +91 22 7115 8008 Management Representative: Hongkong: 800 964 448 • Dr. Saloni Wagh – Managing Director Singapore: 800 101 2045 Secondary Number • Ms. Shivani Wagh – Joint Managing Director USA: 1866 746 2133 • Mr. Krishna Raghunathan - Chief Financial Officer UK: 0808 101 1573 EY IR -Runjhun Jain -Runjhun.Jain1@in.ey.com/ Sneha Salian -Sneha2.Salian@in.ey.com